Sivia Capital Partners LLC Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Sivia Capital Partners LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.6% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,705 shares of the healthcare conglomerate’s stock after buying an additional 143 shares during the quarter. UnitedHealth Group accounts for approximately 0.9% of Sivia Capital Partners LLC’s investment portfolio, making the stock its 21st largest position. Sivia Capital Partners LLC’s holdings in UnitedHealth Group were worth $1,582,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of UNH. Grove Bank & Trust lifted its stake in UnitedHealth Group by 2.8% in the third quarter. Grove Bank & Trust now owns 7,129 shares of the healthcare conglomerate’s stock worth $4,168,000 after acquiring an additional 195 shares during the period. Fiduciary Alliance LLC raised its holdings in UnitedHealth Group by 91.7% in the third quarter. Fiduciary Alliance LLC now owns 2,743 shares of the healthcare conglomerate’s stock worth $1,604,000 after purchasing an additional 1,312 shares in the last quarter. Muirfield Wealth Advisors LLC bought a new position in UnitedHealth Group in the third quarter worth about $256,000. Granite Harbor Advisors Inc. raised its holdings in UnitedHealth Group by 29.1% in the third quarter. Granite Harbor Advisors Inc. now owns 1,096 shares of the healthcare conglomerate’s stock worth $641,000 after purchasing an additional 247 shares in the last quarter. Finally, Empirical Asset Management LLC raised its holdings in UnitedHealth Group by 0.5% in the third quarter. Empirical Asset Management LLC now owns 18,699 shares of the healthcare conglomerate’s stock worth $10,933,000 after purchasing an additional 87 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

NYSE UNH traded up $7.97 during mid-day trading on Monday, hitting $606.02. The stock had a trading volume of 932,354 shares, compared to its average volume of 3,906,047. The firm’s 50 day moving average is $583.64 and its 200 day moving average is $531.35. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The stock has a market capitalization of $559.61 billion, a price-to-earnings ratio of 39.66, a PEG ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same period last year, the company earned $6.14 EPS. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is 55.70%.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, September 25th. Robert W. Baird upped their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. KeyCorp assumed coverage on shares of UnitedHealth Group in a report on Friday. They issued an “overweight” rating and a $675.00 price target on the stock. Finally, Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $617.37.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.